IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11952389 B1

PDFFull Text
Date of Patent:
Apr. 09, 2024

Filed:

May. 03, 2022

Benzodiazepine derivatives as rsv inhibitors

Applicant:

Enanta Pharmaceuticals, Inc., Watertown, MA (US);

Inventors:

Brian C. Shook, Holliston, MA (US);

In Jong Kim, Lexington, MA (US);

Thomas P. Blaisdell, Watertown, MA (US);

Jianming Yu, Plainsboro, NJ (US);

Joseph D. Panarese, Newton, MA (US);

Yat Sun Or, Waltham, MA (US);

Assignee:

Enanta Pharmaceuticals, Inc., Watertown, MA (US);

Attorneys:

Edgar W. Harlan

Carolyn S. Elmore

Elmore Patent Law Group

Primary Examiner:

Bruck Kifle

Int. Cl.
CPC ...
C07D 235/24 (2006.01); A61K 31/5513 (2006.01); A61K 31/56 (2006.01); A61K 31/58 (2006.01); A61K 45/06 (2006.01); A61P 31/14 (2006.01); A61P 31/16 (2006.01); C07D 243/16 (2006.01); C07D 403/12 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01); C07D 471/08 (2006.01); C07D 491/048 (2006.01); C07D 495/04 (2006.01); C07D 498/08 (2006.01); C07D 513/04 (2006.01);
U.S. Cl.
CPC ...
C07D 513/04 (2013.01); A61K 31/5513 (2013.01); A61K 31/56 (2013.01); A61K 31/58 (2013.01); A61K 45/06 (2013.01); C07D 243/16 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 471/08 (2013.01); C07D 491/048 (2013.01); C07D 495/04 (2013.01); C07D 498/08 (2013.01);
Abstract

The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Find Patent Forward Citations

Loading…